Psychiatrists Market Report 2026

The psychiatrists market size has grown strongly in recent years. It will grow from $215.02 billion in 2025 to $228.73 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing prevalence of mental health disorders, expansion of outpatient psychiatric services, rising awareness of mental health conditions, growing acceptance of psychiatric care, availability of trained mental health professionals.

The psychiatrists market size is expected to see strong growth in the next few years. It will grow to $295.75 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing investments in digital mental health solutions, rising demand for personalized psychiatric treatment, expansion of AI-assisted diagnostic tools, growing integration of behavioral health analytics, increasing focus on preventive mental healthcare. Major trends in the forecast period include increasing adoption of telepsychiatry services, rising use of digital mental health platforms, growing integration of precision psychiatry approaches, expansion of multidisciplinary treatment models, enhanced focus on outcome-based mental healthcare.

The rising government support for mental health reforms is expected to drive the growth of the psychiatrist market in the coming years. Mental health reforms involve changes aimed at improving how mental health services are structured, financed, and delivered, with the goal of providing better care, support, and treatment for individuals experiencing mental health conditions. The increase in mental health reforms is largely driven by growing awareness of mental health issues, prompting governments to invest more heavily in services and supportive policies. Psychiatrists contribute to the expansion of government-backed mental health reforms by offering expert insights into treatment needs and outcomes, identifying gaps in existing care systems, and advocating for policies that strengthen mental health services. For example, in May 2023, according to the Department of Health and Social Care, a UK-based government agency, NHS mental health services were planned to support an additional 2 million people, supported by an extra £2.3 ($2.67) billion per year in real terms allocated by 2023-2024. Therefore, increased government backing for mental health reforms is supporting the growth of the psychiatrist market.

The growing prevalence of mental illness is also expected to boost the expansion of the psychiatrist market going forward. Mental illness, or mental health disorders, encompasses a broad range of conditions that affect an individual’s thinking, emotions, and behavior, often interfering with daily functioning. Psychiatrists play a vital role in diagnosing and treating mental illnesses through clinical interviews, psychological assessments, and, when necessary, physical examinations to evaluate symptoms, medical history, and personal circumstances. For instance, in 2025, according to a survey published by the National Alliance on Mental Illness, a US-based grassroots mental health organization, 23.4% of US adults experienced mental illness in 2024, representing 61.5 million people. The survey also reported that 52.1% of adults with mental illness received treatment in 2024, while 9.6% had no health insurance coverage. The surveyed population included 2,866 children and young individuals. Therefore, the increasing prevalence of mental illness is driving the growth of the psychiatrist market.

Major companies operating in the psychiatrists market are introducing innovative solutions, such as interactive mental disorder screening and assessment tools, to expand their reach, improve service delivery, and increase revenue. Mental disorder screening tools are standardized instruments designed to identify and assess potential mental health conditions in individuals. For example, in May 2023, the American Psychiatric Association, a US-based professional organization for psychiatrists, in collaboration with AvoMD, a US-based software company, launched an interactive screening and assessment tool for eating disorders. The tool is available at no cost through electronic health record systems, the APA website, and the AvoMD mobile application, and provides clinicians with step-by-step guidance for screening, assessment, diagnosis, and treatment planning. Designed for pediatricians, family physicians, and mental health professionals including psychiatrists and therapists, the tool supports both desktop and mobile platforms and offers EHR integration. Its key features include comprehensive evaluation and treatment planning resources, covering screening, levels of care, nutrition, exercise, psychotherapy, and related areas, along with simplified documentation through summarized assessment responses.

Major companies operating in the psychiatrists market are Massachusetts General Hospital, Mayo Clinic, Universal Health Services Inc., NewYork Presbyterian University Hospital of Columbia and Cornell, Johns Hopkins Hospital, McLean Hospital, National Center for Neurology and Psychiatry, Wenzhou Kangning Hospital, National Institute of Mental Health and Neurosciences, East London Health and Social Care Partnership NHS Trust, Vidyasagar Institute of Mental Health and Neurosciences, Central Institute of Psychiatry, Institute of Behaviour and Allied Sciences, The University of Tokyo Hospital, Baillie Henderson Hospital, Graylands Hospital, Seiwa Hospital, Tokyo Metropolitan Matsuzawa Hospital, Tokyo Saiseikai Central Hospital, St. Luke's International Hospital, Nightingale Hospital, Tyne and Wear Hospitals NHS Foundation Trust, Forest Independent Hospital, Max Planck Institute of Psychiatry, Kursk Clinical Psychiatric Hospital, Menninger Clinic, Sheppard Pratt Health System, Resnick Neuropsychiatric Hospital at UCLA, Centre for Addiction and Mental Health, Al Amal Psychiatric Complex, King Faisal Specialist Hospital and Research Centre, Denmar Specialist Psychiatrist Hospital PTY Ltd, Umzimzulu Hospital.

North America was the largest region in the Psychiatrists market in 2025. The regions covered in the psychiatrists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the psychiatrists market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the psychiatrists market by increasing costs of imported diagnostic equipment, digital health infrastructure components, telemedicine platforms, and pharmaceutical supplies used in psychiatric care. Healthcare providers in North America and Europe are most affected due to reliance on imported medical technologies, while Asia-Pacific faces higher costs for digital platform deployment. These tariffs are raising operational expenses for psychiatric practices. However, they are also encouraging local software development, regional telehealth infrastructure investment, and domestic production of psychiatric care tools.

The psychiatrists market research report is one of a series of new reports that provides psychiatrists market statistics, including psychiatrists industry global market size, regional shares, competitors with a psychiatrists market share, detailed psychiatrists market segments, market trends and opportunities, and any further data you may need to thrive in the psychiatrists industry. This psychiatrists market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Psychiatrists are medical professionals who diagnose, treat, and prevent mental, emotional, and behavioral disorders. They are licensed practitioners holding an M.D. (Doctor of Medicine) or D.O. (Doctor of Osteopathic Medicine) degree and provide palliative care while treating psychosomatic conditions, mental illnesses, and related disorders. Psychiatrists may operate in private or group practices within their own offices, such as clinics or centers, or work in facilities operated by others, including hospitals or health maintenance organization medical centers.

The main mental disorder categories treated by psychiatrists include alcohol-related mental and behavioral disorders, mental and behavioral disorders due to the use of psychoactive substances, schizophrenia, schizotypal and delusional disorders, mood disorders such as anxiety and depression, and other mental and behavioral conditions. Patient types include inpatient and outpatient populations. The psychology disciplines associated with psychiatric practice include social psychology, abnormal psychology, biological psychology, and others.

The psychiatrists market includes revenues earned by entities by providing psychiatrist services such as mental disorder treatments, anxiety disorders treatments, depression treatments, disruptive behavior and dissocial disorders treatments, and neurodevelopmental disorders treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.